NEXENTIS TECHNOLOGIES INC. Repayments of Long-Term Debt
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Repayments of Long-Term Debt of $700.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2024-04-01
- NEXENTIS TECHNOLOGIES INC. repayments of long-term debt for the quarter ending 2022-12-31 was $2.50K, a 22.24% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. repayments of long-term debt for the quarter ending 2022-09-30 was $1.92K, a 2.68% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. repayments of long-term debt for the quarter ending 2022-06-30 was $1.95K, a 3.68% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. repayments of long-term debt for the quarter ending 2022-03-31 was $2.02K, a 2.23% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. repayments of long-term debt for fiscal 2023 was $700.00K, a 8243.27% increase from fiscal 2022.
- NEXENTIS TECHNOLOGIES INC. repayments of long-term debt for fiscal 2022 was $8.39K, a 6.54% increase from fiscal 2021.
- NEXENTIS TECHNOLOGIES INC. repayments of long-term debt for fiscal 2021 was $7.88K, a 8.29% increase from fiscal 2020.
- NEXENTIS TECHNOLOGIES INC. repayments of long-term debt for fiscal 2020 was $7.27K, a 82.79% decline from fiscal 2019.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2023-12-31 | $700.00K 10-K · filed 2024-04-01 | |||
| 2022-12-31 | $2.50K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $4.42K derived: sum of 2 quarters · filed 2024-04-01 | $6.37K derived: sum of 3 quarters · filed 2024-04-01 | $8.39K 10-K · filed 2024-04-01 |
| 2022-09-30 | $1.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $3.87K derived: sum of 2 quarters · filed 2023-11-14 | $5.89K 10-Q · filed 2023-11-14 | $7.93K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $1.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $3.96K 10-Q · filed 2023-08-14 | $6.01K derived: sum of 3 quarters · filed 2023-08-14 | $7.99K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $2.02K 10-Q · filed 2023-05-15 | $4.07K derived: sum of 2 quarters · filed 2023-05-15 | $6.04K derived: sum of 3 quarters · filed 2023-05-15 | $7.92K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $2.05K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $4.02K derived: sum of 2 quarters · filed 2023-03-27 | $5.90K derived: sum of 3 quarters · filed 2023-03-27 | $7.88K 10-K · filed 2023-03-27 |
| 2021-09-30 | $1.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $3.85K derived: sum of 2 quarters · filed 2022-11-14 | $5.83K 10-Q · filed 2022-11-14 | $7.72K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $1.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $3.85K 10-Q · filed 2022-08-15 | $5.74K derived: sum of 3 quarters · filed 2022-08-15 | $7.57K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $1.98K 10-Q · filed 2022-05-16 | $3.86K derived: sum of 2 quarters · filed 2022-05-16 | $5.69K derived: sum of 3 quarters · filed 2022-05-16 | $7.46K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $1.89K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $3.72K derived: sum of 2 quarters · filed 2022-03-31 | $5.49K derived: sum of 3 quarters · filed 2022-03-31 | $7.27K 10-K · filed 2022-03-31 |
| 2020-09-30 | $1.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $3.60K derived: sum of 2 quarters · filed 2021-11-15 | $5.38K 10-Q · filed 2021-11-15 | $7.41K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $1.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $3.56K 10-Q · filed 2021-08-16 | $5.59K derived: sum of 3 quarters · filed 2021-08-16 | $7.29K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $1.79K 10-Q · filed 2021-05-18 | $3.82K derived: sum of 2 quarters · filed 2021-05-18 | $5.52K derived: sum of 3 quarters · filed 2021-05-18 | $38.25K derived: sum of 4 quarters · filed 2021-05-18 |
| 2019-12-31 | $2.03K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $3.74K derived: sum of 2 quarters · filed 2021-03-29 | $36.46K derived: sum of 3 quarters · filed 2021-03-29 | $42.26K 10-K · filed 2021-03-29 |
| 2019-09-30 | $1.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $34.43K derived: sum of 2 quarters · filed 2020-11-12 | $40.23K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $32.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $38.52K 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | $5.79K 10-Q · filed 2020-05-15 | |||
| 2018-12-31 | $18.94K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |